The number of CD34+ cells mobilized into the peripheral blood can predict the quality of subsequent collection

Journal of Hematotherapy and Stem Cell Research

Volumn 9, Issue 1, 2000, Pages 89-93

  Alcorn, Michael J ^a,c   Farrell, Elizabeth ^a   Barr, John ^a   Pearson, Charles ^a   Green, Rachel ^b   Holyoake, Tessa ^a  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^b SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BIOLOGICAL THERAPY; BLOOD CELL; CALCULATION; CANCER; CELL COUNT; CELL SUBPOPULATION; HUMAN; HUMAN CELL; LEUKAPHERESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANTIGENS, CD34; BODY WEIGHT; CLINICAL PROTOCOLS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKAPHERESIS; QUALITY CONTROL; RETROSPECTIVE STUDIES;

EID: 0034061783     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581600319667     Document Type: Article

References (16)

1. Gianni AM, S Siena, M Bregni, et al. (1989). Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 2:580.
2. Gratwohl A, J Passweg, H Baldomero, et al. (1998). Blood and marrow transplantation activity in Europe 1996. Bone Marrow Transplant 22:227.
3. To LB, MM Roberts, DN Haylock, et al. (1992). Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 9:277.
4. Schmitz N, DC Linch, P Dreger, et al. (1996). Randomised trial of filgrastim-mobilised peripheral blood progenitor transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet 347:353.
5. Haas R, R Möhle, S Frühauf, et al. (1994). Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787.
6. Haynes A, A Hunter, G McQuaker, et al. (1995). Engraftment characteristics of peripheral blood stem cells mobilized with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplant 16:359.
7. Bensinger W, F Applebaum, S Rowley, et al. (1995). Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13:2547.
8. + cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 17:509.
9. Bensinger WI, K Longin, F Applebaum, et al. (1994). Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87:825.
10. Weaver CH, B Hazelton, R Birch, et al. (1995). An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86:3961.
11. + cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 19:303.
12. Glaspy JA, EJ Shpall, CF LeMaistre, et al. (1997). Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood 90:2939.
13. + cell dose on resource utilization in patients after high-dose chemotherapy with peripheral blood stem cell support. J Clin Oncol 17:1227.
14. + cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation. Blood 91:3148.
15. Elliott C, DM Samson, S Armitage, et al. (1996). When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol 14:970.
16. Schwella N, J Beyer, I Schwaner, et al. (1996). Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer. J Clin Oncol 14:1114.